These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The effect of a single course of alpha-2B-interferon in patients with HIV-related and chronic idiopathic immune thrombocytopenia. Fabris F; Sgarabotto D; Zanon E; Francavilla F; Zaggia F; Cadrobbi P; Girolami A Autoimmunity; 1993; 14(3):175-9. PubMed ID: 8329555 [TBL] [Abstract][Full Text] [Related]
5. Interferon therapy in intravenous drug users with HIV-associated idiopathic thrombocytopenic purpura. Stellini R; Rossi G; Paraninfo G Haematologica; 1992; 77(5):418-20. PubMed ID: 1483592 [TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha is effective in the treatment of HIV-1-related, severe, zidovudine-resistant thrombocytopenia. A prospective, placebo-controlled, double-blind trial. Marroni M; Gresele P; Landonio G; Lazzarin A; Coen M; Vezza R; Sinnone MS; Boschetti E; Nosari AM; Stagni G; Nenci GG; Pauluzzi S Ann Intern Med; 1994 Sep; 121(6):423-9. PubMed ID: 8053616 [TBL] [Abstract][Full Text] [Related]
7. alpha Interferon therapy in the treatment of idiopathic thrombocytopenic purpura. Proctor SJ Eur J Cancer; 1991; 27 Suppl 4():S63-8. PubMed ID: 1799483 [TBL] [Abstract][Full Text] [Related]
8. Interferon alpha treatment of chronic hepatitis C in HIV-infected patients receiving zidovudine: efficacy, tolerance and response related factors. Del Pozo MA; Arias JR; Pinilla J; Labarga P; Alcoba M; Martinez de la Cruz FJ; Anton F; Carro JA; Perez MR; Echevarria S; Garrote E; Moreno-Otero R Hepatogastroenterology; 1998; 45(23):1695-701. PubMed ID: 9840131 [TBL] [Abstract][Full Text] [Related]
9. [Exacerbation of an autoimmune thrombocytopenic purpura during treatment with interferon alpha in a woman with chronic viral hepatitis C]. Bacq Y; Sapey T; Gruel Y; Fimbel B; Degenne D; Barin F; Metman EH Gastroenterol Clin Biol; 1996; 20(3):303-6. PubMed ID: 8763070 [TBL] [Abstract][Full Text] [Related]
10. [Interferon therapy of idiopathic thrombocytopenic purpura]. Kaito K; Nishiwaki K; Masuoka H; Shimada T; Yoshida M; Ochiai S; Katayama T; Kobayashi M; Saito A; Watanabe R Rinsho Ketsueki; 1992 Jun; 33(6):776-82. PubMed ID: 1433917 [TBL] [Abstract][Full Text] [Related]
11. Initial observations on the efficacy of highly active antiretroviral therapy in the treatment of HIV-associated autoimmune thrombocytopenia. Aboulafia DM; Bundow D; Waide S; Bennet C; Kerr D Am J Med Sci; 2000 Aug; 320(2):117-23. PubMed ID: 10981487 [TBL] [Abstract][Full Text] [Related]
12. Zidovudine plus interferon-alpha versus zidovudine alone in HIV-infected symptomatic or asymptomatic persons with CD4+ cell counts > 150 x 10(6)/L: results of the Zidon trial. Zidon Study Group. Fernández-Cruz E; Lang JM; Frissen J; Furner V; Châteauvert M; Boucher CA; Dowd P; Stevens J AIDS; 1995 Sep; 9(9):1025-35. PubMed ID: 8527074 [TBL] [Abstract][Full Text] [Related]
13. Alpha-interferon therapy induces improvement of platelet counts in children with chronic idiopathic thrombocytopenic purpura. Donato H; Kohan R; Picón A; Rovó A; Rapetti MC; Schvartzman G; Lavergne M; de Galvagni A; Rosso A; Rendo P J Pediatr Hematol Oncol; 2001 Dec; 23(9):598-603. PubMed ID: 11902304 [TBL] [Abstract][Full Text] [Related]
14. Effect of interferon (IFN) on refractory idiopathic thrombocytopenic purpura: administration of 6 million units of recombinant IFN alpha-2b. Ishii H; Oh H; Uchida Y; Nakamura H; Endo N; Asai T; Yoshida S Intern Med; 1992 Dec; 31(12):1343-7. PubMed ID: 1300169 [TBL] [Abstract][Full Text] [Related]
15. Treatment of condylomata acuminata with pegylated interferon alfa-2b in HIV-infected patients. Brockmeyer NH; Poffhoff A; Bader A; Hochdorfer B; Schlottmann R; Rasokat H; Altmeyer P; Kreuter A Eur J Med Res; 2006 Jan; 11(1):27-32. PubMed ID: 16504957 [TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha therapy in idiopathic thrombocytopenic purpura. Dikici B; Bosnak M; Kara IH; Dogru O; Alkaya A; Hasolat K Pediatr Int; 2001 Dec; 43(6):577-80. PubMed ID: 11737732 [TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS). Krown SE; Gold JW; Niedzwiecki D; Bundow D; Flomenberg N; Gansbacher B; Brew BJ Ann Intern Med; 1990 Jun; 112(11):812-21. PubMed ID: 1971504 [TBL] [Abstract][Full Text] [Related]
18. Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study. Shepherd FA; Beaulieu R; Gelmon K; Thuot CA; Sawka C; Read S; Singer J J Clin Oncol; 1998 May; 16(5):1736-42. PubMed ID: 9586886 [TBL] [Abstract][Full Text] [Related]
19. Low-dose oral recombinant interferon-alpha A in patients with HIV-1 infection: a blinded pilot study. Sperber SJ; Gocke DJ; Haberzettl CA; Pestka S AIDS; 1993 May; 7(5):693-7. PubMed ID: 8100421 [TBL] [Abstract][Full Text] [Related]
20. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat. Rodeghiero F Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]